The longer duration, lower cost of capital alternative to Novel Capital
You'll hate spending weeks on diligence then paying huge fees. Founderpath Offers:
United States
We have used Founderpath as an ongoing source of non-dilutive growth capital for our fast-growing B2B SaaS company, Exercise.com, and have been very impressed with the ease of use, quick response times, and flexibility. Nathan and Kevin are great to work with and I look forward to partnering with them in the future. If you are a growing SaaS company that needs capital to fund future growth I would strongly recommend working with Founderpath.
Use SaaS Financing Software that scales with you. See why SaaS founders are taking money from Founderpath and using our valuation and reporting tools to make it the #1 Novel Capital alternative.
Novel Capital | Founderpath | |
---|---|---|
Interest Rate | 21% | As low as 16% |
Duration | 36 months | 48 months |
Growth Requirement | 10% YoY | None |
Minimum Revenue | $350,000 | $500,000 |
Deals Done | $50m to 100 founders | $130m to 212 founders |
Use of Funds | Bridge between equity rounds | We love bootstrappers |
Built By SaaS Founders? | Yes | Yes |
Products | Revenue based finance with repayment cap | Term Loans, Factoring Agreements |
Repayment Cap Fee | Yes | None |
SaaS Company HQ | US Only | Worldwide |
SaaS Valuation Calculator | ||
CEO Retreats |
Offers made
Revenue on platform